Table 1. Characteristics of patients for... | American Society of Hematology

Table 1.

Characteristics of patients for experiments performed at the Dmitry Rogachev National Medical Research Center of Pediatric Hematology (Figure 3)

Patient no.	Age, y	Sex	PLT count	Diagnosis	Therapy regimen
1	13	Female	201	ALL	Cytarabine, dexamethasone, methotrexate
2	7	Male	105	ALL	Cytarabine, dexamethasone, methotrexate
3	6	Female	356	ALL	Cytarabine, dexamethasone, methotrexate
4	9	Male	415	ALL	Cytarabine, dexamethasone, methotrexate
5	3	Male	421	ALL	Cytarabine, dexamethasone, methotrexate
6	4	Female	103	ALL	Cytarabine, dexamethasone, methotrexate
7	3	Male	293	ALL	Cytarabine, dexamethasone, methotrexate
8	3	Female	489	ALL	Cytarabine, dexamethasone, methotrexate
9	1	Male	280	ALL	Cytarabine, dexamethasone, methotrexate
10	13	Female	198	ALL	Cytarabine, dexamethasone, methotrexate

Patient no.	Age, y	Sex	PLT count	Diagnosis	Therapy regimen
1	13	Female	201	ALL	Cytarabine, dexamethasone, methotrexate
2	7	Male	105	ALL	Cytarabine, dexamethasone, methotrexate
3	6	Female	356	ALL	Cytarabine, dexamethasone, methotrexate
4	9	Male	415	ALL	Cytarabine, dexamethasone, methotrexate
5	3	Male	421	ALL	Cytarabine, dexamethasone, methotrexate
6	4	Female	103	ALL	Cytarabine, dexamethasone, methotrexate
7	3	Male	293	ALL	Cytarabine, dexamethasone, methotrexate
8	3	Female	489	ALL	Cytarabine, dexamethasone, methotrexate
9	1	Male	280	ALL	Cytarabine, dexamethasone, methotrexate
10	13	Female	198	ALL	Cytarabine, dexamethasone, methotrexate

Samples from bone marrow aspirates and autologous blood were taken from each patient, who were undergoing bone marrow biopsy to confirm remission from ALL.

ALL, acute lymphoblastic leukemia; PLT, platelet.

View Large

This Feature Is Available To Subscribers Only